Compounded GLP-1 by medication.

Compounded GLP-1 prescribing has narrowed. The FDA removed semaglutide from its drug-shortage list in February 2025 and tirzepatide in October 2024, and many programs that once offered compounded have since exited. The programs below are the ones still active. For the legal and safety picture, see whether compounded semaglutide is legit and safe.

Cash-pay compounded semaglutide runs from roughly $59 a month (drug price) to $348. Compounded tirzepatide runs from roughly $69 a month (drug price) to $399. For pricing context across the full market, see the GLP-1 cost guide and the full chart.

Compounded semaglutide has no FDA label, so it has no FDA dose schedule. Compounded semaglutide doses puts what each program publishes side by side.